Hani Kim | Executive Director
RIGHT Foundation

Dr. Hani Kim’s educational background is in biology, and she later extended her research into public health. She currently plays an active role in global health as the Executive Director of the RIGHT Foundation. Her career includes positions as a postdoctoral researcher at the Max Planck Institute of Immunobiology, followed by roles as a researcher and professor at Toronto General Hospital and the University of Toronto. She also served as a research director at the Johns Hopkins School of Public Health and worked as a program officer at the Gates Foundation. Hani Kim received her bachelor’s degree from Queen’s University in Canada and holds master’s degree in pharmacology and clinical pathology from the University of Toronto. She additionally obtained a master’s degree in public health from the Johns Hopkins School of Public Health in the United States.

Appearances:

Pre-Congress Workshops - 21st April @ 14:00

DRIVING KOREA’S VACCINE R&D CAPABILITIES TOWARDS REGIONAL AND GLOBAL PUBLIC HEALTH - ROOM 207A

This workshop will be split into two sections, starting with Korea’s Efforts to Contribute to Regional and Global Vaccine R&D, followed by International Partnerships for Vaccine Equity. Join this workshop to meet speakers not only from South Korea, but also from other international Asian markets that are driving vaccine R&D and manufacturing capacity.

2:00 Korea’s Efforts to Contribute to Regional and Global Vaccine R&D

Current and planned efforts by Korean government and industry to support regional and global Vaccine R&D and local manufacturing

2:45 – 3:30 Panel Discussion with the Korean government and industry on current and future international partnerships in vaccine R&D and local manufacturing

3:30 – 3:45 comfort break

3:45 International Partnerships for Vaccine Equity

Collaboration between Korean and international partners to support regional and global health through partnership in R&D and establishment of local manufacturing of vaccine in LMICs

4:15 Panel: What does it take to collaborate for impact on global vaccine equity? What are some best practices of effort for vaccine R&D and local manufacturing in LMICs?

Kevin Kee-Jong Hong, Professor, KOREA mRNA VACCINE INITIATIVE (KmVAC)